High pre-treatment neutrophil-to-lymphocyte ratio as a prognostic marker for worse survival in patients with recurrent/metastatic cervical cancer treated with immune checkpoint inhibitors

OBJECTIVE: To evaluate the association between pre-treatment neutrophil-to-lymphocyte ratio (NLR) and survival outcomes among patients with recurrent/metastatic cervical cancer treated with PD-1/PD-L1 inhibitors. METHODS: A retrospective analysis of patients with recurrent/metastatic cervical cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Calo, Corinne A., Barrington, David A., Brown, Morgan, Gonzalez, Lynette, Baek, Jae, Huffman, Allison, Benedict, Jason, Backes, Floor, Chambers, Laura, Cohn, David, Copeland, Larry, Cosgrove, Casey, Nagel, Christa, O'Malley, David, Bixel, Kristin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287632/
https://www.ncbi.nlm.nih.gov/pubmed/35855965
http://dx.doi.org/10.1016/j.gore.2022.101040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287632/
https://www.ncbi.nlm.nih.gov/pubmed/35855965
http://dx.doi.org/10.1016/j.gore.2022.101040

Ejemplares similares